Case Commentary: Delayed Cerebral Vasculitis Associated with the Development of Ceftriaxone-Resistant Pneumococcal Meningitis

Mizrahi and colleagues present a well-described case of the emergence of drug resistance in Streptococcus pneumoniae meningitis during therapy with ceftriaxone monotherapy with a low bactericidal concentration in the cerebrospinal fluid. Adherence to international guidelines could possibly have prevented the emergence of this resistant isolate and the adverse outcome. ABSTRACT Mizrahi and colleagues present a well-described case of the emergence of drug resistance in Streptococcus pneumoniae meningitis during therapy with ceftriaxone monotherapy with a low bactericidal concentration in the cerebrospinal fluid. Adherence to international guidelines could possibly have prevented the emergence of this resistant isolate and the adverse outcome.

[1]  J. Lewnard,et al.  Dose-specific effectiveness of 7- and 13-valent pneumococcal conjugate vaccines against vaccine-serotype Streptococcus pneumoniae colonization in children. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  B. Pilmis,et al.  Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal Evolution , 2019, Antimicrobial Agents and Chemotherapy.

[3]  F. Tobolowsky,et al.  Delayed Cerebral Injury in Adults With Bacterial Meningitis: A Novel Complication of Adjunctive Steroids?* , 2018, Critical care medicine.

[4]  C. Ginocchio,et al.  Epidemiology of Meningitis and Encephalitis in the United States, 2011–2014 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Zunt,et al.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  C. Whitney,et al.  Community-acquired bacterial meningitis , 2016, Nature Reviews Disease Primers.

[7]  Daniel P. Haeusser,et al.  Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus , 2016, Antimicrobial Agents and Chemotherapy.

[8]  B. Mourvillier,et al.  ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  N. Beeching,et al.  The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. , 2016, The Journal of infection.

[10]  J. Reitsma,et al.  Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis , 2010, Neurology.

[11]  Kalyanakrishnan Ramakrishnan,et al.  Diagnosis and treatment of otitis media. , 2007, American family physician.

[12]  Allan R Tunkel,et al.  Practice guidelines for the management of bacterial meningitis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.